Report - PROGRAMA PRELIMINARPueden notificarse las sospechas de reacciones adversas a la Unidad de Farmacovigilancia de GSK, telf.: 902 202 700/ 900 202 700, fax: 91 8075940, email:[email protected]

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form